Literature DB >> 8067711

Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan.

B H Teh1, J T Lin, W H Pan, S H Lin, L Y Wang, T K Lee, C J Chen.   

Abstract

In order to estimate the seroprevalence and explore multiple risk factors associated with Helicobacter pylori infection among residents in Taiwan, a total of 823 subjects randomly selected from one metropolitan precinct and three townships were studied. Serum samples were tested for IgG antibodies against H. pylori by enzyme-linked immunosorbent assay using commercial kits. The overall seropositive rate was 54.4% with no gender difference (53.7% for males and 55.2% for females). There was a significant geographical variation with the highest seropositive rate (63.4%) in rural area where aborigines live, and where the age-adjusted stomach cancer mortality is highest and the lowest (40.5%) in urban area where Hakkas live, and where the stomach cancer mortality is lowest. There was also an increasing seropositive rate with age from 27.1% for children younger than 10 years old to 72.3% for adults aged more than 40 years old. Age-specific seroprevalence in Taiwan is higher than that in United States, France, Finland and Australia, and lower than that in Algeria, Ivory Coast and India. No association with H. pylori seropositivity was observed for drinking water source, toilet type, family income and educational level after adjusting for age and area. A dose-response relation between H. pylori seropositivity and sibship size was found. Upon further analysis of seroprevalence for children aged 16 or younger, a positive association was observed for birth order and current number of children in family; there was also an inverse association for current number of adults in family. The early childhood transmission among siblings seems an important determinant of H. pylori seropositivity in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067711

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

Review 1.  Helicobacter pylori infection and eradication in paediatric patients.

Authors:  H M Malaty
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

Review 2.  Helicobacter pylori: the size of the problem.

Authors:  J Parsonnet
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

3.  Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease.

Authors:  C J Tsai; T Y Huang
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

4.  Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region.

Authors:  Lee Lai Heng; Priscilla Caguioa; Ng Soo Chin; Tzeon-Jye Chiou; Jong Wook Lee; Yoshitaka Miyakawa; Karmel L Tambunan; Beng H Chong
Journal:  Int J Hematol       Date:  2011-07-16       Impact factor: 2.490

5.  Concordance of Helicobacter pylori infection among children in extended-family homes.

Authors:  P K Garg; S Perry; L Sanchez; J Parsonnet
Journal:  Epidemiol Infect       Date:  2005-11-11       Impact factor: 2.451

6.  The association of drinking water quality and sewage disposal with Helicobacter pylori incidence in infants: the potential role of water-borne transmission.

Authors:  Penny B Travis; Karen J Goodman; Kathleen M O'Rourke; Frank D Groves; Debajyoti Sinha; Joyce S Nicholas; Jim VanDerslice; Daniel Lackland; Kristina D Mena
Journal:  J Water Health       Date:  2010-03       Impact factor: 1.744

7.  Houseflies are an unlikely reservoir or vector for Helicobacter pylori.

Authors:  M S Osato; K Ayub; H H Le; R Reddy; D Y Graham
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Helicobacter pylori: a poor man's gut pathogen?

Authors:  Mohammed Mahdy Khalifa; Radwa Raed Sharaf; Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2010-03-31       Impact factor: 4.181

9.  Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.

Authors:  Lien-Chieh Lin; Tzu-Herng Hsu; Kuang-Wei Huang; Ka-Wai Tam
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

10.  Short-term celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model.

Authors:  Chao-Hung Kuo; Huang-Ming Hu; Pei-Yun Tsai; I-Chen Wu; Sheau-Fang Yang; Lin-Li Chang; Jaw-Yuan Wang; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.